Granate-Marques A, Polis-Yanes C, Seminario-Amez M, Jané-Salas E, López-López J. Medication-related osteonecrosis of the jaw associated with implant and regenerative treatments: Systematic review. Med Oral Patol Oral Cir Bucal. 2019 Mar 1;24 (2):e195-203.
doi:10.4317/medoral.22691
http://dx.doi.org/doi:10.4317/medoral.22691
________________________________________________________________________________________________________________________________________________________________________________________________________________________
References
|
1.
Marx R. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular
necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg.
2003;61:1115–7. |
|
|
|
|
|
2.
Ruggiero S, Mehrotra B, Rosenberg T, Engroff S. Osteonecrosis of the jaws associated
with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac
Surg. 2004;62:527–34. |
|
|
|
|
|
3.
Ruggiero S. An office-based approach to the diagnosis and management of
osteonecrosis. Atlas Oral Maxillofac Surg Clin North Am. 2013;21:167–73. |
|
|
|
|
|
4.
Bagan J V., Murillo J, Jimenez Y, Poveda R, Milian MA, Sanchis JM, et al.
Avascular jaw osteonecrosis in association with cancer chemotherapy: Series
of 10 cases. J Oral Pathol Med. 2005;34:120–3. |
|
|
|
|
|
5.
Koth VS, Figueiredo MA, Salum FG, Cherubini K. Bisphosphonate-related
osteonecrosis of the jaw: from the sine qua non condition of bone exposure to
a non-exposed BRONJ entity. J head neck imaging. 2016;45:20160049. |
|
|
|
|
|
6.
Spanou A, Lyritis GP, Chronopoulos E, Tournis S. Management of
bisphosphonate-related osteonecrosis of the jaw : a literature review. Oral
Dis. 2015;21:927–36. |
|
|
|
|
|
7.
Ribeiro de-Freitas N, Lima L, Boaventura de-Moura M, César Simamoto-Júnior P,
de Magalhães D. Bisphosphonate treatment and dental implants : A systematic
review. Med Oral Patol Oral Cir Bucal. 2016;21:e644–e51. |
|
|
|
|
|
8.
Silva LF, Curra C, Munerato MS, Deantoni CC, Matsumoto MA, Cardoso CL, et al.
Surgical management of bisphosphonate-related osteonecrosis of the jaws :
literature review. Oral Maxillofac Surg Clin North Am. 2016;20:9–17. |
|
|
|
|
|
9. Holzinger D, Seemann R, Matoni N, Ewers R, Millesi W, Wutzl A. Effect of dental implants on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2014;72:1937.e1-8. |
|
|
|
|
|
10.
Fung P, Nicoletti P, Shen Y, Porter S. Pharmacogenetics of
Bisphosphonate-associated Osteonecrosis of the Jaw. Oral Maxillofac Surg Clin
North Am. 2015;27:537–46. |
|
|
|
|
|
11.
Leizaola-Cardesa IO, Aguilar-Salvatierra A, Gonzalez-Jaranay M, Moreu G,
Sala-Romero MJ, Gómez- G. Bisphosphonates, vitamin D, parathyroid hormone,
and osteonecrosis of the jaw. Could there be a missing link? Med Oral Patol
Oral Cir Bucal. 2016;21:e236–40. |
|
|
|
|
|
12.
Polymeri A, Kodovazenitis G, Polymeris A, Komboli M. Bisphosphonates:
Clinical Applications and Adverse Events in Dentistry. Oral Heal Prev Dent.
2015;13:289–99. |
|
|
|
|
|
13.
Carlson ER, Schlott BJ. Anti-Resorptive osteonecrosis of the jaws: Facts
forgotten, questions answered, lessons learned. Oral Maxillofac Surg Clin
North Am. 2014;26:171–91. |
|
|
|
|
|
14.
Boquete-castro A, Calvo-guirado L, Aguilar-salvatierra A, Delgado-ruiz RA.
Denosumab and osteonecrosis of the jaw . A systematic analysis of events
reported in clinical trials. Clin Oral Impl Res. 2015;27:367–75. |
|
|
|
|
|
15.
Katsarelis H, Shah NP, Dhariwal DK, Pazianas M. Infection and
Medication-related Osteonecrosis of the Jaw. J Dent Res. 2015;94:534–9. |
|
|
|
|
|
16.
Matsuo A, Hamada H, Takahashi H, Okamoto A, Kaise H, Chikazu D. Evaluation of
dental implants as a risk factor for the development of bisphosphonate-related
osteonecrosis of the jaw in breast cancer patients. Odontology.
2016;104:363–71. |
|
|
|
|
|
17.
Tennis P, Rothman KJ, Bohn RL, Tan H, Zavras A, Laskarides C, et al.
Incidence of osteonecrosis of the jaw among users of bisphosphonateswith
selecte d cancers or osteoporosis. Pharmacoepidemiol Drug Saf. 2012;21:810–7. |
|
|
|
|
|
18.
Fliefel R, Tröltzsch M, Kühnisch J, Ehrenfeld M, Otto S. Treatment strategies
and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with
characterization of patients: a systematic review. Int J Oral Maxillofac
Surg. 2015;44:568–85. |
|
|
|
|
|
19.
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al.
American Association of Oral and Maxillofacial Surgeons Position Paper on
Medication-Related Osteonecrosis of the Jaw—2014 Update. J Oral Maxillofac
Surg. 2014;72(10):1938–56. |
|
|
|
|
|
20.
Gaudin E, Seidel L, Bacevic M, Rompen E, Lambert F. Occurrence and risk
indicators of medication-related osteonecrosis of the jaw after dental
extraction: A systematic review and meta-analysis. J Clin Periodontol. 2015;42:922–32. |
|
|
|
|
|
21.
Morrison A, Khan A, Tetradis S, Peters E. Osteonecrosis of the Jaw. J Can
Dent Assoc. 2015;81:f19. |
|
|
|
|
|
22.
Ruggiero S, Drew S. Osteonecrosis of the jaws and bisphosphonate therapy. J
Dent Res. 2007;86:1013-21. |
|
|
|
|
|
23.
Bagan J, Jiménez Y, Diaz J, Murillo J, Sanchis J, Poveda R. Osteonecrosis of
the jaws in intravenous bisphosphonate use: proposal for a modification of
the clinical classification. Oral Oncol. 2009;45:645–6. |
|
|
|
|
|
24.
López-Cedrún JL, Sanromán JF, García A, Penarrocha M, Feijoo JF, Limeres J,
et al. Oral bisphosphonate-related osteonecrosis of the jaws in dental
implant patients: A case series. Br J Oral Maxillofac Surg. 2013;51:874–9. |
|
|
|
|
|
25.
Tam Y, Kar K, Nowzari H, Cha HS, Ahn KM. Osteonecrosis of the Jaw after Implant
Surgery in Patients Treated with Bisphosphonates - A Presentation of Six
Consecutive Cases. Clin Implant Dent Relat Res. 2014;16:751–61. |
|
|
|
|
|
26.
Giovannacci I, Meleti M, Manfredi M, Mortellaro C, Greco Lucchina A, Bonanini
M, et al. Medication-Related Osteonecrosis of the Jaw Around Dental Implants.
J Craniofac Surg. 2016;27:697-701. |
|
|
|
|
|
27.
Kwon TG, Lee CO, Park JW, Choi SY, Rijal G, Shin HI. Osteonecrosis associated
with dental implants in patients undergoing bisphosphonate treatment. Clin
Oral Implants Res. 2014;25:632–40. |
|
|
|
|
|
28.
Elm E Von, Altman DG, Egger M, Pocock SJ, Peter C, Gøtzsche P, et al.
guidelines for reporting observational studies Strengthening the reporting of
observational studies in epidemiology (STROBE) statement : guidelines for
reporting observational studies. J Clin Epidemiol. 2008;344:61. |
|
|
|
|
|
29.
Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G, et al.
Preferred reporting items for systematic reviews and meta-analyses: The
PRISMA statement. PLoS Med. 2009;6; e1000097. |
|
|
|
|
|
30.
Jacobsen C, Metzler P, Rössle M, Obwegeser J, Zemann W, Grätz KW.
Osteopathology induced by bisphosphonates and dental implants: Clinical
observations. Clin Oral Investig. 2013;17:167–75. |
|
|
|
|
|
31.
Troeltzsch M, Cagna D, Stähler P, Probst F, Kaeppler G, Troeltzsch M, et al.
Clinical features of peri-implant medication-related osteonecrosis of the
jaw: Is there an association to peri-implantitis? J Cranio-Maxillofacial
Surg. 2016;44:1945–51. |
|
|
|
|
|
32.
Khoury F, Hidajat H. Extensive Autogenous Bone Augmentation and Implantation
in Patients Under Bisphosphonate Treatment: A 15-Case Series. Int J
Periodontics Restorative Dent. 2016;36:9–18. |
|